Home NDC 0703-4502-84 Metoclopramide
Product NDC 0703-4502
Requested package NDC 0703-4502-84
11-digit product format 007034502
Labeler code 0703
Product ID 0703-4502_e640a87c-7ee3-4ca2-9808-3916bfd1a54b
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Metoclopramide
Dosage form INJECTION, SOLUTION
Route INTRAMUSCULAR; INTRAVENOUS
Labeler Teva Parenteral Medicines, Inc.
Application ANDA073135
Marketing category ANDA
Marketing start 1991-12-01
Substance METOCLOPRAMIDE HYDROCHLORIDE
Active strength 5 mg/mL
Pharmacologic classes Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A073135-001 METOCLOPRAMIDE HYDROCHLORIDE METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A073135-001 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A073135-001 METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML INJECTABLE / INJECTION AP 1991-11-27 cb3db0bc1861…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 41 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Metoclopramide
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength METOCLOPRAMIDE HYDROCHLORIDE 5 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination W1792A2RVD Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 311670 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0703-4502-01 Metoclopramide 2 mL in 1 VIAL, SINGLE-USE INJECTION, SOLUTION 2 14 0703-4502-04 Metoclopramide 25 in 1 TRAY INJECTION, SOLUTION 25 14 0703-4502-91 Metoclopramide 2 mL in 1 VIAL, SINGLE-USE INJECTION, SOLUTION 2 8 0703-4502-93 Metoclopramide 10 in 1 CARTON INJECTION, SOLUTION 10 8
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded METOCLOPRAMIDE HYDROCHLORIDE ACTIVE INGREDIENT W1792A2RVD METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] 8 METOCLOPRAMIDE ACTIVE MOIETY L4YEB44I46 METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] 8 HYDROCHLORIC ACID INACTIVE INGREDIENT QTT17582CB METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] 8 SODIUM CHLORIDE INACTIVE INGREDIENT 451W47IQ8X METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] 8 SODIUM HYDROXIDE INACTIVE INGREDIENT 55X04QC32I METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] 8 WATER INACTIVE INGREDIENT 059QF0KO0R METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] 8 METOCLOPRAMIDE HYDROCHLORIDE ACTIVE INGREDIENT W1792A2RVD METOCLOPRAMIDE HYDROCHLORIDE INJECTION [CARDINAL HEALTH] 3 METOCLOPRAMIDE ACTIVE MOIETY L4YEB44I46 METOCLOPRAMIDE HYDROCHLORIDE INJECTION [CARDINAL HEALTH] 3 hydrochloric acid INACTIVE INGREDIENT QTT17582CB METOCLOPRAMIDE HYDROCHLORIDE INJECTION [CARDINAL HEALTH] 3 Sodium Chloride INACTIVE INGREDIENT 451W47IQ8X METOCLOPRAMIDE HYDROCHLORIDE INJECTION [CARDINAL HEALTH] 3 sodium hydroxide INACTIVE INGREDIENT 55X04QC32I METOCLOPRAMIDE HYDROCHLORIDE INJECTION [CARDINAL HEALTH] 3 Water INACTIVE INGREDIENT 059QF0KO0R METOCLOPRAMIDE HYDROCHLORIDE INJECTION [CARDINAL HEALTH] 3 METOCLOPRAMIDE HYDROCHLORIDE ACTIVE INGREDIENT W1792A2RVD METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] 1 METOCLOPRAMIDE HYDROCHLORIDE ACTIVE INGREDIENT W1792A2RVD METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] 1 METOCLOPRAMIDE ACTIVE MOIETY L4YEB44I46 METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] 1 METOCLOPRAMIDE ACTIVE MOIETY L4YEB44I46 METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] 1 HYDROCHLORIC ACID INACTIVE INGREDIENT QTT17582CB METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] 1 HYDROCHLORIC ACID INACTIVE INGREDIENT QTT17582CB METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] 1 SODIUM CHLORIDE INACTIVE INGREDIENT 451W47IQ8X METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] 1 SODIUM CHLORIDE INACTIVE INGREDIENT 451W47IQ8X METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] 1 SODIUM HYDROXIDE INACTIVE INGREDIENT 55X04QC32I METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] 1 SODIUM HYDROXIDE INACTIVE INGREDIENT 55X04QC32I METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] 1 WATER INACTIVE INGREDIENT 059QF0KO0R METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] 1 WATER INACTIVE INGREDIENT 059QF0KO0R METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0703-4502 METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] 13 Current NDC, Legacy NDC, 2 package rows 20230628_cccf04bd-7463-40b8-a41f-cb1093c358d7.zip 0703-4502 METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] 7 Current NDC, Legacy NDC, 2 package rows 20240906_5645a752-8868-4b51-8b59-48bb4276d763.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Metoclopramide METOCLOPRAMIDE Teva Parenteral Medicines, Inc. cccf04bd-7463-40b8-a41f-cb1093c358d7 2026-04-22 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 073135 application number: ANDA073135 ndc (product): 0703-4502 Metoclopramide METOCLOPRAMIDE Teva Parenteral Medicines, Inc. 5645a752-8868-4b51-8b59-48bb4276d763 2026-04-15 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 073135 application number: ANDA073135 ndc (product): 0703-4502 Metoclopramide METOCLOPRAMIDE Cardinal Health 107, LLC 1ecab710-8b7d-4903-80a8-de66562be55a 2025-10-22 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 073135 application number: ANDA073135
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0703-4502-84 00703450284 25 VIAL, SINGLE-USE in 1 TRAY (0703-4502-84) > 2 mL in 1 VIAL, SINGLE-USE (0703-4502-81) 2015-08-17 2021-03-31 No No Current